Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Society for Medical Oncology
Pharma
Novartis, Daiichi, AZ shine in ESMO analysis of cancer approvals
Novartis, Daiichi Sankyo and AstraZeneca emerged as the top drugmakers in an analysis of the clinical value added by new solid tumor cancer medicines.
Kevin Dunleavy
Sep 13, 2024 8:06am
ESMO: Searching for the perfect cup of pharma-branded espress-MO
Oct 20, 2023 7:59am
Regeneron, Sanofi won't dethrone Merck in lung cancer: analysts
Sep 24, 2020 10:41am
New cancer drugs carry high price, add little benefit: studies
Sep 27, 2019 12:05am
Can BMS' new Opdivo data uphold its small-cell lung cancer nod?
Dec 13, 2018 12:15pm
Half of doctors are still wary of PARPs: executive
Oct 24, 2018 11:06am
